糖尿病血脂异常的治疗进展  

Progress in the study of dyslipidemia in diabetes

作　　者：赵碧婷 Zhao Biting(Dali University Clinical Medical College,Dali,Yunnan 671000,China)

机构地区：[1]大理大学临床医学院,云南大理671000

出　　处：《医药前沿》2020年第5期14-15,共2页Journal of Frontiers of Medicine

摘　　要：本文对减少糖尿病相关的CVD的方法进行分析,包括降低LDL、TG和增加HDL。目前降低糖尿病患者心血管疾病风险的常用药物为他汀类药物,其他降脂药能否降低心血管风险,仍在进一步研究证实中。It reviews strategies to reduce diabetes-associatedCVD,including reducing low-density lipoprotein levels,lowering triglycerides,and increasing high-density lipoproteins(HDL).The most powerful evidence for reducing cardiovascular disease in diabetic patients today is the use of statins.Whether other lipid-lowering drugs can reduce residual cardiovascular risk is still under investigation.

关 键 词：糖尿病 动脉粥样硬化 低密度脂蛋白 甘油三酯 高密度脂蛋白 

分 类 号：R587.1[医药卫生—内分泌]